We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Mammoth Biosciences Presents AACC 2021 Disruptive Technology Award Finalist CRISPR-Based Detection Platform

By LabMedica International staff writers
Posted on 29 Sep 2021

Illustration

Mammoth Biosciences (San Francisco, CA, USA) presented its revolutionary CRISPR-based detection platform that is enabling limitless testing possibilities and was also one of the AACC 2021 Disruptive Technology award finalists.

Mammoth has catalyzed a new approach to molecular diagnostics, called DETECTR. Based on CRISPR, this programmable platform acts as a search engine for biology and is capable of finding and identifying any nucleic acid sequence in the genome. Using proprietary technology licensed exclusively from the University of California, Berkeley and developed internally, Mammoth is working on multiple form factors and test targets from infectious diseases to cancer. For example, DETECTR was configured in less than two weeks to detect SARS-CoV-2, demonstrating the platform’s ability to be quickly tailored to identify any DNA or RNA target. The resulting product, DETECTR BOOST, is a reagent kit that when combined with standard laboratory automation provides labs with unparalleled high throughput molecular testing.

Mammoth was also one of the AACC 2021 Disruptive Technology award finalists. AACC's Disruptive Technology Award Competition recognizes innovative testing and disruptive technology solutions that improve patient care through diagnostic performance or access to high quality testing. It provides an opportunity for early to mid-stage start-ups in the medical device, diagnostic, or digital health/health IT spaces to showcase their technology and present to a large audience and a panel of judges.

Related Links:
Mammoth Biosciences

Visit expo >

Gold Member

Quantitative POC Immunoassay Analyzer

EASY READER+

POC Helicobacter Pylori Test Kit
Hepy Urease Test

Gold Member

Hybrid Pipette

SWITCH

Automated Chemiluminescence Immunoassay Analyzer

MS-i3080

ADLM

Latest AACC 2021 News

Channels

Clinical Chemistry

view channel

Study Compares Analytical Performance of Quantitative Hepatitis B Surface Antigen Assays

Hepatitis B virus (HBV) continues to pose a significant global health challenge, with chronic infection affecting hundreds of millions of people despite effective vaccines and antiviral therapies.... Read more

Blood Test Could Predict and Identify Early Relapses in Myeloma Patients

Multiple myeloma is an incurable cancer of the bone marrow, and while many patients now live for more than a decade after diagnosis, a significant proportion relapse much earlier with poor outcomes.... Read more

Image: The sensitive Raman imaging system can detect very faint signals from SERS nanoparticles that bind to tumor markers (Photo courtesy of Zhen Qiu/Michigan State University)

Compact Raman Imaging System Detects Subtle Tumor Signals

Accurate cancer diagnosis often depends on labor-intensive tissue staining and expert pathological review, which can delay results and limit access to rapid screening. These conventional methods also make... Read more

Noninvasive Blood-Glucose Monitoring to Replace Finger Pricks for Diabetics

People with diabetes often need to measure their blood glucose multiple times a day, most commonly through finger-prick blood tests or implanted sensors. These methods can be painful, inconvenient, and... Read more

Molecular Diagnostics

view channel

Image: Blood protein signature may help identify cancer earlier in patients with non-specific symptoms (Photo courtesy of Shutterstock)

Simple Blood Test Detects Cancer in Patients with Non-Specific Symptoms

Patients who seek medical care for non-specific symptoms such as fatigue, unexplained pain, or weight loss often pose a diagnostic challenge. These symptoms can be caused by cancer, other serious diseases,... Read more

New Method Accurately Predicts Asthma Attacks Five Years in Advance

Asthma affects more than 500 million people worldwide and remains a leading cause of preventable hospital visits and healthcare costs. A major challenge in asthma care is the inability to reliably identify... Read more

Image: Researchers have identified a previously unrecognized molecular subgroup of meningiomas (photo courtesy of Adobe Stock)

Hidden Genetic Subgroup Sheds New Light on Brain Tumors

Meningiomas are the most common primary tumors of the central nervous system and are typically treated with surgery or radiation, as targeted therapies remain limited. They account for more than one-third... Read more

Image: Advanced single-cell analysis identifies new surface markers on circulating tumor cells in aggressive breast cancer (Wikimedia Commons, CC BY-SA 4.0)

Liquid Biopsy Approach Enhances Detection of Aggressive Breast Cancer Cells

Triple-negative breast cancer (TNBC) is the most aggressive form of breast cancer and lacks targeted therapies. It spreads more readily through the bloodstream, and metastasis is responsible for most breast... Read more

Hematology

view channel

Image: The AI model analyzes routine blood test data to distinguish between genetic subtypes of alpha thalassemia (Photo courtesy of Adobe Stock)

AI Algorithm Effectively Distinguishes Alpha Thalassemia Subtypes

Alpha thalassemia affects millions of people worldwide and is especially common in regions such as Southeast Asia, where carrier rates can reach extremely high levels. While the condition can have significant... Read more

MRD Tests Could Predict Survival in Leukemia Patients

Acute myeloid leukemia is an aggressive blood cancer that disrupts normal blood cell production and often relapses even after intensive treatment. Clinicians currently lack early, reliable markers to predict... Read more

Platelet Activity Blood Test in Middle Age Could Identify Early Alzheimer’s Risk

Early detection of Alzheimer’s disease remains one of the biggest unmet needs in neurology, particularly because the biological changes underlying the disorder begin decades before memory symptoms appear.... Read more

Image: Sickle cell disease patients with higher levels of RMVs, AMVs, and EMVs were found to have more severe disease (Photo courtesy of Adobe Stock)

Microvesicles Measurement Could Detect Vascular Injury in Sickle Cell Disease Patients

Assessing disease severity in sickle cell disease (SCD) remains challenging, especially when trying to predict hemolysis, vascular injury, and risk of complications such as vaso-occlusive crises.... Read more

Immunology

view channel

Blood Test Identifies Lung Cancer Patients Who Can Benefit from Immunotherapy Drug

Small cell lung cancer (SCLC) is an aggressive disease with limited treatment options, and even newly approved immunotherapies do not benefit all patients. While immunotherapy can extend survival for some,... Read more

Whole-Genome Sequencing Approach Identifies Cancer Patients Benefitting From PARP-Inhibitor Treatment

Targeted cancer therapies such as PARP inhibitors can be highly effective, but only for patients whose tumors carry specific DNA repair defects. Identifying these patients accurately remains challenging,... Read more

Ultrasensitive Liquid Biopsy Demonstrates Efficacy in Predicting Immunotherapy Response

Immunotherapy has transformed cancer treatment, but only a small proportion of patients experience lasting benefit, with response rates often remaining between 10% and 20%. Clinicians currently lack reliable... Read more

Blood Test Could Identify Colon Cancer Patients to Benefit from NSAIDs

Colon cancer remains a major cause of cancer-related illness, with many patients facing relapse even after surgery and chemotherapy. Up to 40% of people with stage III disease experience recurrence, highlighting... Read more

Microbiology

view channel

AI-Powered Platform Enables Rapid Detection of Drug-Resistant C. Auris Pathogens

Infections caused by the pathogenic yeast Candida auris pose a significant threat to hospitalized patients, particularly those with weakened immune systems or those who have invasive medical devices.... Read more

New Test Measures How Effectively Antibiotics Kill Bacteria

Antibiotics are typically evaluated by how well they inhibit bacterial growth in laboratory tests, but growth inhibition does not always mean the bacteria are actually killed. Some pathogens can survive... Read more

New Antimicrobial Stewardship Standards for TB Care to Optimize Diagnostics

Antibiotic resistance is rising worldwide, threatening the effectiveness of treatments for major infectious diseases, including tuberculosis (TB). Resistance to key TB drugs, such as bedaquiline, is of... Read more

Image: Test strips with various uropathogenic bacterial species that are responsible for the majority of urinary tract infections (Photo courtesy of Henning Sabersky-Müssigbrodt/TUM)

New UTI Diagnosis Method Delivers Antibiotic Resistance Results 24 Hours Earlier

Urinary tract infections affect around 152 million people every year, making them one of the most common bacterial infections worldwide. In routine medical practice, diagnosis often relies on rapid urine... Read more

Pathology

view channel

Image: Single-cell sequencing reveals how early cancer-driving mutations alter gene activity in individual cells within human tissue (Photo courtesy of Shutterstock)

Single-Cell Profiling Technique Could Guide Early Cancer Detection

Cancer often develops silently over many years, as individual cells acquire mutations that give them a growth advantage long before a tumor forms. These pre-malignant cells can exist alongside normal cells... Read more

Image: Comparative analysis of SRUV PA virtual histology images of human kidney tissues (Byullee Park et al., Science Advances, 2025; DOI:10.1126/sciadv.adz1820)

Intraoperative Tumor Histology to Improve Cancer Surgeries

Surgical removal of cancer remains the first-line treatment for many tumors, but ensuring that all cancerous tissue is removed while preserving healthy tissue is a major challenge. Surgeons currently rely... Read more

Rapid Stool Test Could Help Pinpoint IBD Diagnosis

Inflammatory bowel disease (IBD) is a chronic condition in which the immune system mistakenly attacks the digestive tract, causing persistent gut inflammation. Diagnosis and disease monitoring often depend... Read more

AI-Powered Label-Free Optical Imaging Accurately Identifies Thyroid Cancer During Surgery

Thyroid cancer is the most common endocrine cancer, and its rising detection rates have increased the number of patients undergoing surgery. During tumor removal, surgeons often face uncertainty in distinguishing... Read more

Technology

view channel

Aptamer Biosensor Technology to Transform Virus Detection

Rapid and reliable virus detection is essential for controlling outbreaks, from seasonal influenza to global pandemics such as COVID-19. Conventional diagnostic methods, including cell culture, antigen... Read more

AI Models Could Predict Pre-Eclampsia and Anemia Earlier Using Routine Blood Tests

Pre-eclampsia and anemia are major contributors to maternal and child mortality worldwide, together accounting for more than half a million deaths each year and leaving millions with long-term health complications.... Read more

Image: AI-designed peptide sensors respond to cancer-associated enzymes and generate detectable signals in urine (Photo courtesy of MIT)

AI-Generated Sensors Open New Paths for Early Cancer Detection

Cancers are far easier to treat when detected early, yet many tumors remain invisible until they are advanced or have recurred after surgery. Early-stage disease often produces signals that are too weak... Read more

Pioneering Blood Test Detects Lung Cancer Using Infrared Imaging

Detecting cancer early and tracking how it responds to treatment remains a major challenge, particularly when cancer cells are present in extremely low numbers in the bloodstream. Circulating tumor cells... Read more

Industry

view channel

WHX Dubai Labs (formerly Medlab Middle East) will be held at Dubai World Trade Centre from 10-13 February

WHX Labs Dubai to Gather Global Experts in Antimicrobial Resistance at Inaugural AMR Leaders’ Summit

World Health Expo (WHX) Labs in Dubai (formerly Medlab Middle East), which will be held at Dubai World Trade Centre from 10-13 February, will address the growing global threat of antimicrobial resistance... Read more

BD and Penn Institute Collaborate to Advance Immunotherapy through Flow Cytometry

BD (Becton, Dickinson and Company, Franklin Lakes, NJ, USA) has entered into a strategic collaboration with the Institute for Immunology and Immune Health (I3H, Philadelphia, PA, USA) at the University... Read more

Abbott Acquires Cancer-Screening Company Exact Sciences

Abbott (Abbott Park, IL, USA) has entered into a definitive agreement to acquire Exact Sciences (Madison, WI, USA), enabling it to enter and lead in fast-growing cancer diagnostics segments.... Read more

$Image: Freenome will evaluate Roche\'s forthcoming SBX technology for future development applications (Photo courtesy of Roche)$

Roche and Freenome Collaborate to Develop Cancer Screening Tests

Roche (Basel, Switzerland) and Freenome (Brisbane, CA, USA have entered into a strategic collaboration to commercialize Freenome's cancer screening technology in international markets.... Read more